Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE 2

Journal of Lipid Research

Volumn 53, Issue 4, 2012, Pages 630-642

  Alcolea, Sonia ^a   Antón, Rosa ^a   Camacho, Mercedes ^a   Soler, Marta ^a   Alfranca, Arantzazu ^b   Avilés Jurado, Francesc Xavier ^c   Redondo, Juan Miguel ^b   Quer, Miquel ^a   León, Xavier ^a   Vila, Luis ^a  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Arachidonic acid; Cyclooxygenase; Interleukin 1; Prostaglandin E

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE 1; PROSTANOID; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL; CELL CULTURE; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; FIBROBLAST; FLOW CYTOMETRY; HEAD AND NECK CANCER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MOLECULAR INTERACTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; THERMOSTABILITY; UPREGULATION;

ARACHIDONIC ACID; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; CHEMICAL FRACTIONATION; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; DINOPROSTONE; FIBROBLASTS; HEAD AND NECK NEOPLASMS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMIDAZOLES; INTERLEUKIN-1; INTRAMOLECULAR OXIDOREDUCTASES; NEOVASCULARIZATION, PATHOLOGIC; PROSTAGLANDINS F; PROTEIN ARRAY ANALYSIS; PROTEIN STABILITY; PYRIDINES; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84859394518     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M019695     Document Type: Article

References (45)

1. Marnett, L. J. 1992. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52: 5575-5589.
2. Vila, L. 2004. Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis. Med. Res. Rev. 24: 399-424. (Pubitemid 38802696)
3. Smith, W. L., D. L. DeWitt, and R. M. Garavito. 2000. Cyclo oxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69: 145-182.
4. Itoh, S., K. Matsui, I. Furuta, and Y. Takano. 2003. Immunohistochemical study on overexpression of cyclooxygenase- 2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor. Oral Oncol. 39: 829-835. (Pubitemid 38373467)
5. Camacho, M., X. León, M. T. Fernández-Figueras, M. Quer, and L. Vila. 2008. Prostaglandin E 2 pathway in head and neck squamous cell carcinoma (HNSCC). Head Neck. 30: 1175-1181.
6. Kulmacz, R. J. 2005. Regulation of cyclooxygenase catalysis by hydroperoxides. Biochem. Biophys. Res. Commun. 338: 25-33. (Pubitemid 41540533)
7. Murakami, M., Y. Nakatani, T. Tanioka, and I. Kudo. 2002. Prostaglandin E synthase. Prostaglandins Other Lipid Mediat. 68-69: 383-399. (Pubitemid 35247409)
8. Marwali M.R., and J.L. Mehta. 2006. COX-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studies. Thromb. Haemost. 96: 401-406.
9. McAdam, B. F., F. Castella-Lawson, I. A. Mardini, S. Kapoor, J. A. Lawson, and G. A. FitzGerald. 1999. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc. Natl. Acad. Sci. USA. 96: 272-277. (Pubitemid 29036089)
10. Jung, T. T., N. T. Berlinger, and S. K. Juhn. 1985. Prostaglandins in squamous cell carcinoma of the head and neck: a preliminary study. Laryngoscope. 95: 307-312. (Pubitemid 15137353)
11. 2pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 30: 377-386.
12. Wang, D., and R. N. DuBois. 2006. Prostaglandins and cancer. Gut. 55: 115-122. (Pubitemid 41820645)
13. Soler, M., M. Camacho, J. R. Escudero, M. A. Iñiguez, and L. Vila. 2000. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. Circ. Res. 87: 504-507.
14. 2 biosynthesis in vascular smooth muscle cells. J. Thromb. Haemost. 5: 1411-1419.
15. 2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells. Kidney Int. 70: 1935-1941.
16. 2 by tumor cells. Arterioscler. Thromb. Vasc. Biol. 29: 1131-1137.
17. Yoshimatsu, K., N. K. Altorki, D. Golijanin, P. B. Paty, R. A. Soslow, P. J. Jakobsson, R. A. DeLellis, K. Subbaramaiah, and A. J. Dannenberg. 2001. Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. Clin. Cancer Res. 7: 2669-2674. (Pubitemid 32911370)
18. Yoshimatsu, K., D. Golijanin, P. B. Paty, R. A. Soslow, P. J. Jakobsson, R. A. DeLellis, K. Subbaramaiah, and A. J. Dannenberg. 2001. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin. Cancer Res. 7: 3971-3976. (Pubitemid 34044615)
19. Jabbour, H. N., S. A. Milne, A. R. Williams, R. A. Anderson, and S. C. Boddy. 2001. Expression of COX-2 and PGE synthase and synthesis of PGE2 in endometrial adenocarcinoma: a possible autocrine/ paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Br. J. Cancer. 85: 1023-1031. (Pubitemid 33016005)
20. Golijanin, D., J. Y. Tan, A. Kazior, E. G. Cohen, P. Russo, G. Dalbagni, K. J. Auborn, K. Subbaramaiah, and A. J. Dannenberg. 2004. Cyclooxygenase-2 and microsomal prostaglandin E synthase-1 are overexpressed in squamous cell carcinoma of the penis. Clin. Cancer Res. 10: 1024-1031. (Pubitemid 38198904)
21. Iñiguez, M. A., A. Rodriguez, O. V. Volpert, M. Fresno, and J. M. Redondo. 2003. Cyclooxygenase-2: a therapeutic target in angiogenesis. Trends Mol. Med. 9: 73-78. (Pubitemid 36313868)
22. Murakami, M., and I. Kudo. 2006. Prostaglandin E synthase: a novel drug target for inflammation and cancer. Curr. Pharm. Des. 12: 943-954.
23. Bhowmick, N. A., and H. L. Moses. 2005. Tumor-stroma interactions. Curr. Opin. Genet. Dev. 15: 97-101. (Pubitemid 40127637)
24. Hu, M., and K. Polyak. 2008. Microenvironmental regulation of cancer development. Curr. Opin. Genet. Dev. 18: 27-34. (Pubitemid 351694443)
25. Shimoda, M., K. T. Mellody, and A. Orimo. 2010. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin. Cell Dev. Biol. 21: 19-25.
26. Franco, O. E., A. K. Shaw, D. W. Strand, and S. W. Hayward. 2010. Cancer associated fibroblasts in cancer pathogenesis. Semin. Cell Dev. Biol. 21: 33-39.
27. Brú, A., J. C. Souto, S. Alcolea, R. Antón, A. Remacha, M. Camacho, M. Soler, I. Brú, A. Porres, and L. Vila. 2009. Tumour cell lines HT-29 and FaDu produce proinflammatory cytokines and activate neutrophils in vitro. Possible applications for neutrophil-based anti-tumour treatment. Mediators Inflamm. 2009: 817498.
28. Souto, J. C., L. Vila, and A. Brú. 2011. Polymorphonuclear neutrophils and cancer. Intense and sustained neutrophilia as a treatment against solid tumors. Med. Res. Rev. 31: 311-363.
29. Godessart, N., M. Camacho, J. López-Belmonte, R. Antón, M. García, J. M. de Moragas, and L. Vila. 1996. Prostaglandin H-synthase-2 is the main enzyme involved in the biosynthesis of octadecanoids from linoleic acid in human dermal fibroblasts stimulated with IL- 1β. J. Invest. Dermatol. 107: 726-732. (Pubitemid 26371089)
30. Camacho, M., J. López-Belmonte, and L. Vila. 1998. Rate of vaso-constrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and PGI-synthase activity. Circ. Res. 83: 353-365. (Pubitemid 28389965)
31. Camacho, M., N. Godessart, R. Antón, M. García, and L. Vila. 1995. Interleukin-1 enhances the ability of cultured umbilical vein endothelial cells to oxidize linoleic acid. J. Biol. Chem. 270: 17279-17286.
32. Alfranca, A., J. M. López-Oliva, L. Genís, D. López-Maderuelo, I. Mirones, D. Salvado, A. J. Quesada, A. G. Arroyo, and J. M. Redondo. 2008. PGE2 induces angiogenesis via MT1-MMP-mediated activation of the TGFbeta/Alk5 signaling pathway. Blood. 112: 1120-1128.
33. Meckmongkol, T. T., R. Harmon, P. McKeown-Longo, and L. Van De Water. 2007. The fibronectin synergy site modulates TGF-beta-dependent fibroblast contraction. Biochem. Biophys. Res. Commun. 360: 709-714. (Pubitemid 47082433)
34. 5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-β1 activation and myofibroblast differentiation. J. Biol. Chem. 285: 22382-22393.
35. Dinarello, C. A. 2010. Why not treat human cancer with interleukin- 1 blockade? Cancer Metastasis Rev. 29: 317-329.
36. Dinarello, C. A. 2011. Interleukin1 in the pathogenesis and treatment of inflammatory diseases. Blood. 117: 3720-3732.
37. Lewis, A. M., S. Varghese, H. Xu, and H. R. Alexander. 2006. Interleukin-1 and cancer progression: the emerging role of interleukin- 1 receptor antagonist as a novel therapeutic agent in cancer treatment. J. Transl. Med. 4: 48.
38. Chen, Z., P. S. Malhotra, G. R. Thomas, F. G. Ondrey, D. C. Duffey, C. W. Smith, I. Enamorado, N. T. Yeh, G. S. Kroog, S. Rudy, et al. 1999. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin. Cancer Res. 5: 1369-1379. (Pubitemid 29282941)
39. Schuon, R., J. Brieger, R. L. Fanke, R. Jakob, and W. J. Mann. 2005. Increased PGE 2 levels in nonmalignant mucosa adjacent to squamous cell carcinoma of head and neck. ORL J. Otorhinolaryngol Relat Spec. 67: 96-100. (Pubitemid 40868744)
40. Romano, M., and J. Claria. 2003. Cyclooxygenase-2 and 5- lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J. 17: 1986-1995. (Pubitemid 37392443)
41. Williams, C. S., M. Tsujii, J. Reese, S. K. Dey, and R. N. DuBois. 2000. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Invest. 105: 1589-1594. (Pubitemid 30390309)
42. Seno, H., M. Oshima, T. O. Ishikawa, H. Oshima, K. Takaku, T. Chiba, S. Narumiya, and M. M. Taketo. 2002. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res. 62: 506-511. (Pubitemid 34110434)
43. Tlsty, T. D., and L. M. Coussens. 2006. Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 1: 119-150.
44. West, R. B., and M. van de Rijn. 2007. Experimental approaches to the study of cancer-stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis. Lab. Invest. 87: 967-970. (Pubitemid 47429192)
45. Sonoshita, M., K. Takaku, N. Sasaki, Y. Sugimoto, F. Ushikubi, S. Narumiya, M. Oshima, and M. M. Taketo. 2001. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nat. Med. 7: 1048-1051. (Pubitemid 32937386)